VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹33.90 | ₹21.31 | ₹19.87 | ₹30.47 | ₹50.04 |
What is the latest Earnings Per Share (EPS) of VENUS REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹33.90 |
| Mar2024 | ₹21.31 |
| Mar2023 | ₹19.87 |
| Mar2022 | ₹30.47 |
| Mar2021 | ₹50.04 |
How is Earnings Per Share (EPS) of VENUS REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹33.90 | 59.08 | |
| Mar2024 | ₹21.31 | 7.25 | |
| Mar2023 | ₹19.87 | -34.79 | |
| Mar2022 | ₹30.47 | -39.11 | |
| Mar2021 | ₹50.04 | - | |
Compare Earnings Per Share (EPS) of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,357.6 Cr | -2.2% | 75% | 298.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -2.2% |
75% |
298.3% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses